Dr Tan Shi Ming, Senior Consultant Orthopaedic Surgeon
Centurion Orthopaedic Centre
KNEE PAIN ON THE RISE
Osteoarthritis is the most common musculoskeletal condition affecting joints, particularly in the lower limb joints – including hips, knees and ankles. Knee osteoarthritis prevalence has increased significantly over the past few decades that up to 250 million people worldwide are affected. This prevalence is expected to rise in part due to obesity and other risk factors such as increasing age, prior knee injuries such as fractures, ligament and meniscal tears as well as the participation in endurance and high impact sports such as marathon running, football, basketball and racquet games.
WHAT IS CARTILAGE?
Joint cartilage (also referred to as articular cartilage) is a tissue made up of cells known as chondrocytes and extracellular matrix (ECM, the environment around cells). This matrix is composed of water (more than 70%) and organic components such as hyaluronic acid, collagen and other components. The composition of the ECM is important to maintain nutrition and health of the articular cartilage. Chondrocytes play a key role in keeping the joint environment healthy by producing both the building blocks of cartilage (ECM components) and the enzymes that break down old or damaged components. This balance helps the body maintain homeostasis — its way of keeping everything in check and working properly. This symbiotic relationship between the cells and its matrix is essential in ensuring the overall health and function of the articular cartilage, allowing it to withstand forces across the joint both in motion and at rest.
WHAT HAPPENS IN OSTEOARTHRITIS?
Osteoarthritis is a medical condition in which there is inflammation of the joint tissues, characterized by the degeneration of chondrocytes. This is usually precipitated by excessive mechanical loading or a prior knee injury such as ligament, meniscal or chondral injury.
Osteoarthritis often presents with symptoms of joint pain, swelling, stiffness in the early stages and joint deformities and loss of range of motion in the late stages. In advanced stages, the joint will develop contractures and impede the ability to walk.

In the early stages of osteoarthritis, too much stress on the joint or past injuries cause chondrocytes to produce more enzymes that break down cartilage. This leads to a loss of important ECM components and a decline in its quality. . In a bid to maintain the ECM, chondrocytes continue to produce increased quantities of the various ECM components — but over time, they struggle to keep up.
In the later stages of osteoarthritis, the balance between production of ECM components and degradation enzymes becomes disrupted continually. With continued wear of the chondrocytes and an altered environment, inflammation sets in — creating a vicious cycle where inflammation causes more chondrocyte damage, and the damage in turn fuels more inflammation.
WHAT IS VISCOSUPPLEMENTATION?
Various non-surgical therapeutic modalities have been used to treat osteoarthritis, each having its role and efficacy. Viscosupplementation is a non-operative, intra-articular treatment option that is based on the physiologic importance of hyaluronic acid within the ECM of articular cartilage. It usually comes in the form of hyaluronic acid injections.
The goal of this treatment is to restore the viscoelasticity of the joint. It’s similar to restoring the engine oil and shock absorbers of a car. This would reduce pain, improve mobility and restore the natural protective functions of hyaluronic acid in the joint. In the short term, patients would experience the pain relief benefits from viscosupplementation. The long-term effects are to restore joint mobility and improve joint lubrication, shock absorption and the ability to reduce mechanical stress on cartilage. Additionally, viscosupplementation provides anti-inflammatory effects, reducing symptoms produced from joint inflammation such as pain, swelling and reduced motion.
Viscosupplementation is a simple, short and highly effective treatment option for osteoarthritis of major joints such as the knee, ankle, hip and shoulder. It can be performed in a clinic or day surgery setting, under local anaesthesia, with or without mild sedation. The joint is first cleansed well with antiseptic solution, which is followed by the administration of local anaesthetic to the site of injection. Hyaluronic acid injection is then injected into the joint, followed by the placement of a comfortable bandage.

WHO SHOULD CONSIDER VISCOSUPPLEMENTATION?
Whilst viscosupplementation is an effective treatment option for joint osteoarthritis, it is important to undergo a proper and comprehensive evaluation of your joint condition by a trained musculoskeletal doctor before undergoing the procedure. This may entail a careful understanding of your symptoms, a confirmation of your condition and its severity with a physical assessment and tests.
Patients who have mild to moderate osteoarthritis would benefit most from viscosupplementation. These patients usually exhibit a good range of joint motion, have minimal bony deformities and exhibit early symptoms such as joint pain, swelling and stiffness.
Other patients who have been shown to respond well to this treatment include patients who have had meniscal or ligamentous injuries or previous surgeries such as menisectomy, meniscal repair and/or ligament reconstruction. Another group of patients who would benefit are patients who cannot tolerate anti-inflammatory pain agents (due to drug allergies, medication side effects and co-morbidities) and those who are seeking to delay surgeries.
WHY CHOOSE CINGAL?
Various formulations of viscosupplementation are available in the market. These are broadly categorized into low and high molecular formulations, with the latter being favoured in terms of stronger and longer-lasting effects.

Cingal is the first and only approved combination viscosupplement, formulated to provide combined benefits of both cross-linked high molecular hyaluronic acid and a premium corticosteroid (triamcinolone hexacetonide). This gives it its edge as a fast-acting and long-lasting pain reliever from joint osteoarthritis. It is administered as a convenient single injection with a strong safety profile due to its non-avian bio-fermented source of hyaluronic acid, making it suitable for patients who are sensitive to avian proteins.
Cingal is available across major hospitals, orthopaedic centres, and GP clinics throughout Singapore — speak to your doctor today to find out which treatment best suits your lifestyle and take the first step toward lasting relief from knee pain.
FAQ’S ON VISCOSUPPLEMENTATION
- What is the downtime after a viscosupplementation procedure?
There is minimal downtime after an intra-articular injection of hyaluronic acid. Minimal pain and swelling are experienced for a short period and patients are allowed to weight-bear on the injected joint immediately. - How long do the effects of viscosupplementation last?
The length of effects varies amongst individuals. The majority of patients will have some improvement in their pain as soon as days after the intra-articular procedure. These effects have been shown to last up to 6 months in individuals. - Are there any side-effects from viscosupplementation?
Low incidences of increased pain and swelling, joint infections, or injury to nerve and blood vessels have been reported. These can be further reduced by choosing experienced medical professionals in administering the procedures.
To view the full article, head over to Centurion Orthopaedic Centre







